“Our mission is to be the premier service provider of clinical development solutions to pharma and biotech companies by offering thought leadership, scientific rigor and global quality standards.” - Dr. A. S. Arvind COO, Clinigene

Established in the year 2000 as a Biocon subsidiary, Clinigene became India's first CAP (College of American Pathologists) accredited Central Laboratory. Clinigene's services now span a broad spectrum of activities including human pharmacology, clinical operations, clinical development, clinical data management & biostatistics, regulatory, bioanalytical research and central laboratory services supporting early phase through late-phase clinical development programs. All activities are carried out in strict compliance with regulatory and ICH GCP requirements.

Our comprehensive investigator database and expertise in various therapeutic areas like Diabetology, Oncology, Cardiology, Neuropsychiatry, Nephrology, Immunology, Rheumatology, Infectious diseases and Gastroenterology offer us significant leverage in providing faster patient recruitment, cost competitive trials, yet world-class clinical support. Quick turnaround time and personalized attention to customer needs sets us apart from our peers. Conforming to the highest standards of ethics, patients under investigation are assured of their rights, safety and confidentiality.

With India emerging as a credible destination for conducting global clinical trials, Clinigene is positioned for dynamic growth. Our proven scientific excellence together with full-scale clinical research capabilities enable us to undertake and deliver challenging studies for our global partners.